M Ventures
VC
INVESTOR TYPE
Active
STATUS
29
PROFESSIONALS
91
INVESTMENTS
47
PORTFOLIO
14
EXITS
Description
Founded in 2009, M Ventures is the corporate venture arm of the Merck Group and headquarters in Amsterdam, The Netherlands with additional offices in Germany, Israel, and the United States. The firm seeks to invest in early-stage companies operating in the technology and medical sectors.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2009
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Accelerator/Incubator
Venture Capital
Primary Office
- Gustav Mahlerplein 102
- Toyo lto Building, 20th Floor
- 1082 MA Amsterdam
- Netherlands
M Ventures Investments (91)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Immunitas Therapeutics | 21-Nov-2019 | Early Stage VC | 0000 | Biotechnology | Startup | |
| 0000000 000000 | 17-Jul-2019 | 00000 00000 | 00.000 | Drug Discovery | Generating Revenue/Not Profitable | 00000 00000 00.0 |
| 00000 | 09-Jul-2019 | 0000 00000 | 000 | Food Products | Generating Revenue | |
| 00000000 000000000 | 24-Jun-2019 | 0000 00000 | 00.000 | Biotechnology | Startup | |
| 0000 00000 | 17-Jun-2019 | 0000 00000 | 000 | Financial Software | Generating Revenue | |
| 00000000 | 04-Jun-2019 | 00000 00000 | Biotechnology | Generating Revenue | 0000 000000000 00.0 | |
| 000000 | 03-Jun-2019 | 0000 00000 | 000 | Application Specific Semiconductors | Startup | |
| 0000000 | 30-May-2019 | 00000 00000 | 00.00 | Decision/Risk Analysis | Generating Revenue | 000000000 00000000 |
| Feelit Technologies | 30-May-2019 | Seed Round | 000.00 | Business/Productivity Software | Generating Revenue | |
| Riffyn | 29-May-2019 | Early Stage VC | 000.00 | Business/Productivity Software | Generating Revenue | 0000 00000 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore M Ventures’s full profile, request a free trial.
M Ventures Exits (14)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Progyny | 25-Oct-2019 | IPO | 00000 | Completed |
|
| 000000000 000 | 28-Jun-2018 | 000 | 00000 | Completed |
|
| 0000000 0000000000 | 16-Mar-2018 | 000000000000000000 | 00.000 | Completed |
|
| 000000 | 26-Jan-2017 | 000 | 000.00 | Completed |
|
| 0000000 0000000000 | 01-Apr-2016 | 000000000000000000 | 00000 | Completed |
|
| 00000 | 17-Jun-2015 | 0000000000 | 00000 | Completed |
|
| 000000000000000 | 06-May-2015 | 000000000000000000 | 000.00 | Completed |
|
| 000000 00000000000 | 24-Feb-2015 | 000000000000000000 | 00000 | Completed |
|
| Raze Therapeutics | 01-Jan-2015 | Out of Business | Completed |
|
|
| Galecto | 03-Nov-2014 | Merger/Acquisition | 00000 | Completed |
M Ventures Team (67)
35 Former Team Members
You’re viewing 5 of 67 team members. Get the full list »M Ventures Co-Investors (178)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Alexandria Venture Investments | 4 | 0 | |
| Novo Holdings | 0 | 0 | |
| Pfizer Ventures | 0 | 0 | 0 |
| SR One | 0 | 0 | 0 |
| Sofinnova Partners | 0 | 0 |